Section: Publications

Postdoctoral Position Available

Andrew Fischer, M.D.

Academic Role: Professor

Faculty Appointment(s) In:
   Pathology

Other Affiliation(s):
   Cell Biology

Selected Publications:

Borrello MG, Alberti L, Fischer A, Degl’Innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L, Mantovani A, Pierotti MA. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.  PNAS, 102(41):14825-14830, 2005.

Angeletti C, Harvey N, Khomitch V, Fischer A, Levenson R, and Rimm D.  Detection of malignancy in cytology specimens using spectral-spatial analysis.  Lab Invest, 85:1555-1564, 2005.

Jiang Z, Li C, Fischer A, Dresser K, Woda B. Using AMACR(P504S)/34bE12/p63 cocktail for the detection of small focal prostate carcinoma on needle biopsy specimens. Am J Clin Pathol 123(2):231-236, 2005.

Zink D, Fischer AH, Nickerson JA.  Nuclear structure in cancer cells.  Nature Reviews Cancer 4:677-687, 2004.

Rezk S, Brynes RK, Nelson V, Thein M, Patwardhan N, Fischer A, Khan A. b-Catenin expression in thyroid follicular lesions: Potential role in nuclear envelope changes in papillary carcinomas.  Endocrine Path 15 (4):329-38, 2004.

Hill DA, Chiosea S, Jamaluddin MS, Roy K, Fischer AH, Boyd D, Nickerson JA, and Imbalzano AN. Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.  J Cell Sci 117(24):5847-54, 2004.

Fischer AH, Young K, DeLellis R:  Incorporating Pathologists’ criteria of malignancy into the evolutionary model for cancer development.  J Cellular Biochem 93(1):28-36, 2004.

Lin X, Fischer AH, Ryu KY, Cho JY,Kloos RT, Mazzaferri EL, Jhiang SM. Application of the Cre-LoxP system to enhance thyroid targeted expression of sodium iodide symporter.  J Clin Endocrin Metab. 89(5):2344-2350, 2004.

Fischer AH, Bardarov S, Jiang Z.  Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer.  J Cellular Biochem. 91:170-84, 2004

Fischer AH, Taysavang P, Jhiang SM. Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 163(3):1091-1099, 2003.

Zhu Z, Gandi M, Nikiforova MN, Fischer AH, Nikiforov YE.  Molecular profile and clinical pathologic features of the follicular variant of papillary thyroid carcinoma: An unusually high prevalence of RAS mutations.  Am J Clin Pathol 120(1):71-77, 2003.

Fischer AH, Taysavang P, Weber C, Wilson KL.  Nuclear envelope organization in papillary thyroid carcinoma. Histology and Histopathology 16(1): 1-14, 2001.

Office: Three Biotech
Phone: 508-793-6140
Fax: 508-793-6110
E-mail: Andrew.Fischer@umassmemorial.org
Keywords: Oncogenes/tumor suppressors, Cell Dynamics, Cancer Biology, Nuclear Architecture, Histopathology

More on Andrew Fischer's Research Research | Publications | Biography View All Sections on One Page

Postdoctoral Position Available http://www.umassmed.edu/pathology/fellowship/ One position is available in July 2009 for an ACGME-accredited one-year Cytopathology Fellowship. The Fellowship is unique in integrating Cell Biology concepts related to Cytopathology, and offering basic research opportunities directly related to Cell Biology and Cytopathology into the year. Candidates must be AP or AP/CP eligible, and preference will be given to candidates interested in participating in ongoing research relating to the molecular basis of diagnostic morphologic cellular changes in cancer.  The full curriculum includes a strong foundation in classical morphologic diagnosis (55,000 GYN, 8000 non-GYN per year), FNA performance and interpretation (total 2000 FNA's per year), integration of Molecular Pathology and flow cytometry, cytopreparatory methods, and laboratory management.  Stipend is determined by years of post-graduate experience.